A Merck & Co drug that helps the immune system fight cancer was about twice as effective as the current standard therapy for patients with recurrent or advanced head and neck cancers, according to study data released on Friday.
from Zee News :Zee News - Health http://bit.ly/1J8WBHs via Health News Daily
No comments:
Post a Comment